Comparison of 18F-AlF-NOTA-PRGD2 and 18F-FDG PET/CT Imaging in a Case of Primary Uveal Melanoma

From the ∗NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi

†Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing

‡Department of Ophthalmology, Jiangnan University Medical Center JUMC, Wuxi No. 2 People’s Hospital, Wuxi, Jiangsu Province, China.

Received for publication December 11, 2023; revision accepted January 8, 2024.

X.Z. and D.P. are co-first authors; they contributed equally to this work.

Conflicts of interest and sources of funding: none declared. This article was supported by the Project of Jiangsu Commission of Health (H2023150) and the Major Project of Wuxi Municipal Health Commission (Z202303).

The patient provided written informed consent to participate in the novel diagnostics and authorized the publication of her case and medical data.

Correspondence to: Ke Wang, PhD, Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, No. 20 Qianrong Rd, Wuxi 214063, Jiangsu Province, China. E-mail: [email protected]; or Wenjun Zou, MD, Department of Ophthalmology, Jiangnan University Medical Center JUMC, Wuxi No. 2 People’s Hospital, No. 68 Zhongshan Rd, Wuxi 214000, Jiangsu Province, China. E-mail: [email protected].

留言 (0)

沒有登入
gif